US FDA seeks to accelerate clinical trials of new medicines by using AI to streamline the laborious process of collecting and submitting study data

The FDA's move to use AI in streamlining clinical trials indicates a potential shift in how quickly new medicines can reach the market.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

UK Ministers are planning to relax regulations on what jet fuel airlines can use to keep planes flying this summer,The iPaper reports

NY Fed RRP op demand at 0.64bln (prev. 0.36bln) across 6 counterparties (prev. 5) on April 28th

US FDA seeks to accelerate clinical trials of new medicines by using AI to streamline the laborious process of collecting and submitting study data

Iraqi security forces open fire at drone flying over Baghdad’s Green Zone, security sources reports

Dynatrace (DT) announces USD 1bln buyback programme; will engage with activist StarBoard following its substantial investment

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This could enhance the innovation landscape and improve investor sentiment towards biotech and healthcare sectors. Overall, it positions the U.S. as a leader in integrating technology into healthcare, which may have broader implications for the equities market.

Related headlines

The whole workspace, free to try.

Try it free